Sanfilippo syndrome type B, or mucopolysaccharidosis type IIIB, result
s from defects in the gene for alpha-N-acetylglucosaminidase (NAGLU);
only a few mutations have been described. To rapidly identify most NAG
LU mutations, an automated sequencing procedure was developed for anal
ysis of the entire coding region, including exon-intron borders. By th
is method, eight affected families were studied, and the mutations in
all 16 alleles were identified, more than doubling the number of publi
shed mutations for this gene. Eight mutations were described for the f
irst time: five missense mutations (Y140C, Y455C, P521L, SG12G, and R6
74C), two nonsense mutations (W675X and Q706X), and one 24-nucleotide
insertion. Currently, 36% of all point mutations (8 of 22 alleles) inv
olve R674, a codon having a CpG dinucleotide in the critical initial p
osition. Other mutations were found in more than one family, raising t
he possibility that some may be relatively common and, possibly, ancie
nt mutations. Six new nonpathological mutations were also identified a
nd likely represent polymorphic variants of the NAGLU gene, two of whi
ch might alter enzyme level. Establishing genotype-phenotype relations
hips will be vital in the evaluation of experimental treatments such a
s gene therapy.